• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Dibona Jason

    5/17/23 4:17:27 PM ET
    $AERC
    Environmental Services
    Utilities
    Get the next $AERC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    DiBona Jason

    (Last) (First) (Middle)
    C/O MOLEKULE GROUP, INC.
    10455 RIVERSIDE DRIVE

    (Street)
    PALM BEACH GARDEN FL 33410

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Molekule Group, Inc. [ MKUL ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    05/15/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Rule 10b5-1(c) Transaction Indication

      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/15/2023 F 28,750 D $1.71 671,250 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    /s/ Ryan Tyler, attorney-in-fact for Mr. DiBona 05/17/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AERC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AERC

    DatePrice TargetRatingAnalyst
    6/14/2022Buy → Hold
    The Benchmark Company
    2/1/2022Speculative Buy
    Benchmark
    More analyst ratings

    $AERC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AeroClean Technologies downgraded by The Benchmark Company

      The Benchmark Company downgraded AeroClean Technologies from Buy to Hold

      6/14/22 7:14:46 AM ET
      $AERC
      Environmental Services
      Utilities
    • Benchmark initiated coverage on AeroClean Technologies

      Benchmark initiated coverage of AeroClean Technologies with a rating of Speculative Buy

      2/1/22 12:29:46 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by AeroClean Technologies Inc.

      25-NSE - Molekule Group, Inc. (0001872356) (Subject)

      11/20/23 8:46:42 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/4/23 8:47:38 PM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/3/23 3:25:23 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AeroClean Technologies and Molekule Announce the Close of All-Stock Merger

      Establishes an industry-leading provider of premium, FDA-cleared air purification products and solutionsPositions the combined company to selectively pursue additional value-creating M&A opportunities within the broader indoor air quality ("IAQ") and cleantech industriesPowerful brand value and large installed base of over 350,000 air purification units creates an opportunity to drive recurring revenues through consumables and the launch of a software solution to monitor and control air quality on an enterprise-wide basisRecent developments include the release of Molekule's PECO-HEPA Tri-Power Filter for Air Pro, Air Mini+ and Air Mini; AeroClean's Pūrgo™ air purifier receiving FDA clearance

      1/12/23 9:00:00 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean's Pūrgo™ Air Purifier Receives FDA Clearance for the Elimination of SARS-CoV-2

      Additional Testing Being Performed to Confirm Elimination of Influenza and RSV PALM BEACH GARDENS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today announced that, the U.S. Food and Drug Administration ("FDA") has granted AeroClean 510k clearance (K223328) to update its Pūrgo™ air purifier's ("Pūrgo™") indications for use to include the elimination of SARS-CoV-2, the RNA virus that causes COVID-19. The FDA has reviewed the laboratory performance data and confirmed the applicability of Pūrgo to remove SARS-CoV-2 from the air in indoor environments. The clearance adds SARS-CoV-2 to th

      12/7/22 8:36:24 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Reports Third Quarter 2022 Financial Results

      PALM BEACH GARDENS, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today reported financial results for the three and nine months ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Highlights and Recent Developments The Company entered into a definitive agreement with Molekule, Inc. ("Molekule"), a market leader for premium air purifiers, to combine in an all-stock merger that the Company believes will establish a combined company as a market leader for premium, FDA-cleared air purification products, and solutions.Molekule recently began collaboration with key customers across th

      11/14/22 8:55:00 AM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Dibona Jason

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:17:27 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Tyler Ryan

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:15:43 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Khoury Amin J

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      4/20/23 7:57:21 PM ET
      $AERC
      Environmental Services
      Utilities